Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Pharming Group N.V. - Filing #5829944

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31
Disclosure of effect of changes in foreign exchange rates [text block]	—		—	—	—	—	—	—	—	—	—	—
Disclosure of information when currency is not exchangeable into another currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets	—	—	—	121,545,000 USD	—	—	—	—	146,512,000 USD	—	—	—
Current assets	—	—	—	278,440,000 USD	—	—	—	—	316,342,000 USD	—	—	—
Non-current liabilities	—	—	—	105,122,000 USD	—	—	—	—	166,105,000 USD	—	—	—
Current liabilities	—	—	—	73,802,000 USD	—	—	—	—	77,968,000 USD	—	—	—
Revenue	—	297,200,000 USD	—	—	—	—	—	245,316,000 USD	—	—	—	—
Profit (loss)	— USD	11,841,000 USD	— USD	—	— USD	11,841,000 USD	— USD	10,548,000 USD	—	— USD	10,548,000 USD	— USD
Other comprehensive income	— USD	11,901,000 USD	— USD	—	11,901,000 USD	— USD	— USD	7,103,000 USD	—	— USD	— USD	7,103,000 USD
Comprehensive income	— USD	23,742,000 USD	— USD	—	10,346,000 USD	13,396,000 USD	— USD	3,445,000 USD	—	— USD	10,548,000 USD	7,103,000 USD